| Product Code: ETC8279751 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Genomic Medicine Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Genomic Medicine Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Genomic Medicine Market - Industry Life Cycle |
3.4 Mexico Genomic Medicine Market - Porter's Five Forces |
3.5 Mexico Genomic Medicine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Mexico Genomic Medicine Market Revenues & Volume Share, By End- User, 2021 & 2031F |
4 Mexico Genomic Medicine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of genetic disorders in Mexico |
4.2.2 Growing awareness and adoption of personalized medicine |
4.2.3 Government initiatives to promote genomic research and healthcare |
4.3 Market Restraints |
4.3.1 High cost associated with genomic testing and treatments |
4.3.2 Limited accessibility to advanced genomic technologies in certain regions of Mexico |
5 Mexico Genomic Medicine Market Trends |
6 Mexico Genomic Medicine Market, By Types |
6.1 Mexico Genomic Medicine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Mexico Genomic Medicine Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Mexico Genomic Medicine Market Revenues & Volume, By Oncology, 2021- 2031F |
6.1.4 Mexico Genomic Medicine Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.1.5 Mexico Genomic Medicine Market Revenues & Volume, By Paediatrics, 2021- 2031F |
6.1.6 Mexico Genomic Medicine Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.1.7 Mexico Genomic Medicine Market Revenues & Volume, By Respiratory Medicine, 2021- 2031F |
6.1.8 Mexico Genomic Medicine Market Revenues & Volume, By Rare Genetic Disorders, 2021- 2031F |
6.1.9 Mexico Genomic Medicine Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Mexico Genomic Medicine Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Mexico Genomic Medicine Market, By End- User |
6.2.1 Overview and Analysis |
6.2.2 Mexico Genomic Medicine Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 Mexico Genomic Medicine Market Revenues & Volume, By Clinics, 2021- 2031F |
6.2.4 Mexico Genomic Medicine Market Revenues & Volume, By Academic Institutions, 2021- 2031F |
6.2.5 Mexico Genomic Medicine Market Revenues & Volume, By Research Institutions, 2021- 2031F |
7 Mexico Genomic Medicine Market Import-Export Trade Statistics |
7.1 Mexico Genomic Medicine Market Export to Major Countries |
7.2 Mexico Genomic Medicine Market Imports from Major Countries |
8 Mexico Genomic Medicine Market Key Performance Indicators |
8.1 Number of research grants/funding allocated to genomic medicine projects in Mexico |
8.2 Percentage increase in the number of genetic testing facilities across the country |
8.3 Adoption rate of genomic medicine practices by healthcare providers in Mexico |
9 Mexico Genomic Medicine Market - Opportunity Assessment |
9.1 Mexico Genomic Medicine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Mexico Genomic Medicine Market Opportunity Assessment, By End- User, 2021 & 2031F |
10 Mexico Genomic Medicine Market - Competitive Landscape |
10.1 Mexico Genomic Medicine Market Revenue Share, By Companies, 2024 |
10.2 Mexico Genomic Medicine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here